191 related articles for article (PubMed ID: 9637541)
1. Transfection of the type II TGF-beta receptor into colon cancer cells increases receptor expression, inhibits cell growth, and reduces the malignant phenotype.
MacKay SL; Auffenberg T; Tannahill CL; Ksontini R; Josephs MD; Nowak M; Moldawer LL; Copeland EM
Ann Surg; 1998 Jun; 227(6):781-9. PubMed ID: 9637541
[TBL] [Abstract][Full Text] [Related]
2. Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells.
Wang J; Sun L; Myeroff L; Wang X; Gentry LE; Yang J; Liang J; Zborowska E; Markowitz S; Willson JK
J Biol Chem; 1995 Sep; 270(37):22044-9. PubMed ID: 7665626
[TBL] [Abstract][Full Text] [Related]
3. Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors.
MacKay SL; Yaswen LR; Tarnuzzer RW; Moldawer LL; Bland KI; Copeland EM; Schultz GS
Ann Surg; 1995 Jun; 221(6):767-76; discussion 776-7. PubMed ID: 7794080
[TBL] [Abstract][Full Text] [Related]
4. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.
Ye SC; Foster JM; Li W; Liang J; Zborowska E; Venkateswarlu S; Gong J; Brattain MG; Willson JK
Cancer Res; 1999 Sep; 59(18):4725-31. PubMed ID: 10493532
[TBL] [Abstract][Full Text] [Related]
5. Enhanced tumorigenesis and reduced transforming growth factor-beta type II receptor in lung tumors from mice with reduced gene dosage of transforming growth factor-beta1.
Kang Y; Mariano JM; Angdisen J; Moody TW; Diwan BA; Wakefield LM; Jakowlew SB
Mol Carcinog; 2000 Oct; 29(2):112-26. PubMed ID: 11074608
[TBL] [Abstract][Full Text] [Related]
6. Reduced expression of transforming growth factor beta type I receptor contributes to the malignancy of human colon carcinoma cells.
Wang J; Han W; Zborowska E; Liang J; Wang X; Willson JK; Sun L; Brattain MG
J Biol Chem; 1996 Jul; 271(29):17366-71. PubMed ID: 8663343
[TBL] [Abstract][Full Text] [Related]
7. Mutations of transforming growth factor beta 1 type II receptor, BAX, and insulin-like growth factor II receptor genes in microsatellite unstable cell lines.
Carethers JM; Pham TT
In Vivo; 2000; 14(1):13-20. PubMed ID: 10757056
[TBL] [Abstract][Full Text] [Related]
8. Alteration of cell growth and morphology by overexpression of transforming growth factor beta type II receptor in human lung adenocarcinoma cells.
Kim TK; Mo EK; Yoo CG; Lee CT; Han SK; Shim YS; Kim YW
Lung Cancer; 2001; 31(2-3):181-91. PubMed ID: 11165397
[TBL] [Abstract][Full Text] [Related]
9. Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta.
Vincent F; Nagashima M; Takenoshita S; Khan MA; Gemma A; Hagiwara K; Bennett WP
Oncogene; 1997 Jul; 15(1):117-22. PubMed ID: 9233784
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta (TGF-beta)-induced down-regulation of cyclin A expression requires a functional TGF-beta receptor complex. Characterization of chimeric and truncated type I and type II receptors.
Feng XH; Filvaroff EH; Derynck R
J Biol Chem; 1995 Oct; 270(41):24237-45. PubMed ID: 7592630
[TBL] [Abstract][Full Text] [Related]
11. Reduction in transforming growth factor-beta type II receptor in mouse lung carcinogenesis.
Jakowlew SB; Moody TW; You L; Mariano JM
Mol Carcinog; 1998 May; 22(1):46-56. PubMed ID: 9609100
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta 1 and its receptors in human lung cancer and mouse lung carcinogenesis.
Kang Y; Prentice MA; Mariano JM; Davarya S; Linnoila RI; Moody TW; Wakefield LM; Jakowlew SB
Exp Lung Res; 2000 Dec; 26(8):685-707. PubMed ID: 11195465
[TBL] [Abstract][Full Text] [Related]
13. Defective expression of transforming growth factor beta receptor type II is associated with CpG methylated promoter in primary non-small cell lung cancer.
Zhang HT; Chen XF; Wang MH; Wang JC; Qi QY; Zhang RM; Xu WQ; Fei QY; Wang F; Cheng QQ; Chen F; Zhu CS; Tao SH; Luo Z
Clin Cancer Res; 2004 Apr; 10(7):2359-67. PubMed ID: 15073112
[TBL] [Abstract][Full Text] [Related]
14. Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells.
Sun L; Wu G; Willson JK; Zborowska E; Yang J; Rajkarunanayake I; Wang J; Gentry LE; Wang XF; Brattain MG
J Biol Chem; 1994 Oct; 269(42):26449-55. PubMed ID: 7929366
[TBL] [Abstract][Full Text] [Related]
15. A kinase-defective transforming growth factor-beta receptor type II is a dominant-negative regulator for human breast carcinoma MCF-7 cells.
Ko Y; Koli KM; Banerji SS; Li W; Zborowska E; Willson JK; Brattain MG; Arteaga CL
Int J Oncol; 1998 Jan; 12(1):87-94. PubMed ID: 9454891
[TBL] [Abstract][Full Text] [Related]
16. Decreased stability of transforming growth factor beta type II receptor mRNA in RER+ human colon carcinoma cells.
Jiang W; Tillekeratne MP; Brattain MG; Banerji SS
Biochemistry; 1997 Dec; 36(48):14786-93. PubMed ID: 9402753
[TBL] [Abstract][Full Text] [Related]
17. Expression and autoregulation of transforming growth factor beta receptor mRNA in small-cell lung cancer cell lines.
Nørgaard P; Spang-Thomsen M; Poulsen HS
Br J Cancer; 1996 May; 73(9):1037-43. PubMed ID: 8624260
[TBL] [Abstract][Full Text] [Related]
18. Mutations of the transforming growth factor-beta type II receptor gene are strongly related to sporadic proximal colon carcinomas with microsatellite instability.
Akiyama Y; Iwanaga R; Ishikawa T; Sakamoto K; Nishi N; Nihei Z; Iwama T; Saitoh K; Yuasa Y
Cancer; 1996 Dec; 78(12):2478-84. PubMed ID: 8952554
[TBL] [Abstract][Full Text] [Related]
19. Reversion of transcriptional repression of Sp1 by 5 aza-2' deoxycytidine restores TGF-beta type II receptor expression in the pancreatic cancer cell line MIA PaCa-2.
Venkatasubbarao K; Ammanamanchi S; Brattain MG; Mimari D; Freeman JW
Cancer Res; 2001 Aug; 61(16):6239-47. PubMed ID: 11507078
[TBL] [Abstract][Full Text] [Related]
20. Expression of transforming growth factor beta1 and its type II receptor in mouse colon tumors induced by azoxymethane.
Wang QS; Guda K; Papanikolaou A; Dong M; Rosenberg DW
Int J Oncol; 2000 Sep; 17(3):551-8. PubMed ID: 10938397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]